Jordan Miller, MD


Jordan Miller, MD: 2024 Dermatology Predictions

Advancements in assistance from artificial intelligence include ambient listening to take notes during physician and patient conversations.

Pahroul Davé, APN


The Dx and Rx of Congenital Malalignment Syndrome in Children

Congenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.

Maggie L. Shaw


Eczema Prevalence Varies by Race and Ethnicity, With Overall Increase Seen

Investigators compared these outcomes due to limited research in the space, with previous surveys suggesting care disparities.

Jill Waibel, MD


Jill Waibel, MD, FAAD: Innovations in Laser Modalities for the Treatment of Scars

Waibel shared pearls in laser therapy and other scar treatment modalities in her talks at the American Academy of Dermatology Annual Meeting.

Laura Joszt, MA


Comparison of Psoriatic Arthritis Therapies Finds Bimekizumab More Effective Than Guselkumab

A matching-adjusted indirect comparison found that some patients with PsA are more likely to achieve long-term treatment outcomes with bimekizumab.

Girish Gupta, MB ChB, FRCP


85% of Survey Respondents Do Not Know What Actinic Keratosis Is

The survey conducted by Almirall included participants in the US and Europe.

Patty Weasler


Pulsed Dye Lasers for Cosmetic Procedures

Pulsed dye lasers are now being used for several different dermatologic conditions.

Omar A. Ibrahimi, MD, PhD


New Tech for Skin

There are many innovative and exciting developments coming to the dermatology space, both energy-based devices and injectables.

Alex Biese


Rare Immune Cell May Predict Immunotherapy Response in Melanoma

Vd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.

Bernard A. Cohen, MD


A Novel Approach to Distinguishing Scabies From Atopic Dermatitis

The WHO underscores the significance of addressing scabies as a neglected skin disease, especially in regions with limited health care access.

Matt Leavitt, DO


Matt Leavitt, DO, Discusses the Importance of Hair Loss Awareness Month

Hair loss affects self-esteem and feelings of well-being, but exciting treatments are on the horizon.

Nicholas Brownstone, MD


Psoriasis Therapies in 2024 and Beyond

This article will highlight recently approved psoriasis therapies that will shape the 2024 treatment landscape and provide some exciting updates in the psoriasis management market this coming year and beyond.

Katherine Economy, MD


Navigating Pregnancy, Dermatology, and Drug Safety

Katherine Economy, MD, discusses the challenges and opportunities of treating pregnant patients with dermatologic conditions, emphasizing the importance of comprehensive medication reviews, patient-centered decision-making, and the need for including pregnant patients in clinical trials.

Brad Glick, DO, MPH, FAOCD


Lifestyle Factors Influencing Treatment Plans

Brad Glick, DO, MPH, says it is essential to consider patient lifestyles when choosing atopic dermatitis therapies.

Lauren Miller, PA-C


Lauren Miller, PA-C, Highlights the Value of Collaboration With APPs and More

Miller is presenting 3 sessions at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

Monica Harilall, PA-C, MMS


Case 2: Male, 20 Years Old

An expert in the management of skin conditions provides an overview of a 20-year-old male diagnosed with atopic dermatitis, discussing key insights from a round table discussion. The conversation focused on effective management strategies, best practices for prior authorization approvals, and the significance of treatment vehicles.

Andrew Weinstein, MD, FAAD


Expert Perspectives on BOLT clinical trial data

John Strasswimmer, MD, PhD comments on the impressive utility of both vismodegib and sonidegib in patients with advanced basal cell carcinoma and Jonathan S Zager, MD, FACS, FSSO provides his insight into the clinical utility of both of these treatments.

Lindsey Carr, Editor


Clinical Considerations for Monkeypox in Pregnancy

What we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.

Marta Calbet, PhD


Expert Insights Into the Relationship Between the Hippo Pathway and Extensive Fibrosis in HS

Researchers from the University of Michigan and Almirall found that the profibrotic fibroblast response in HS can be modulated through inhibition of the Hippo pathway.



3 Things You Should Know About the Pathogenesis and Treatment of HS

This CME credit opportunity delves into the pathogenesis and management of hidradenitis suppurativa.

Jennifer Barrett


FDA approves topical for actinic keratosis

Tirbanibulin (Klisyri, Almirall) has been approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of actinic keratosis on the face or scalp.

Nick Loftin


5 steps to make telehealth work for physicians and patients

There are barriers to telehealth adoption that physicians must overcome to realize the technology’s promise.

Jonathan Alicea


Psoriasis Associated with Increased Risk for Retinal Diseases

More research is needed to understand the pathogenesis underlying this association.

Thy Huynh, MD


Dermatologic differences in a diverse population

Understanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.

Jenna Le


Seasonal Efficacy and Tolerability of Tazarotene in Warmer vs Colder Months

Researchers have explored whether the adverse effects of tazarotene are exacerbated during the colder winter months and whether there is variation in treatment efficacy and tolerability between cold vs warm seasons.

© 2024 MJH Life Sciences

All rights reserved.